Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy.

Bonfanti, P; Landonio, S; Ricci, E; Martinelli, C; Fortuna, P; Faggion, I; Quirino, T

Bonfanti, P; Landonio, S; Ricci, E; Martinelli, C; Fortuna, P; Faggion, I; Quirino, T.

J Acquir Immune Defic Syndr ; 27(3): 316-8, 2001 Jul 01.

Article in En | MEDLINE | ID: mdl-11464155

Subject(s)

Antiretroviral Therapy, Highly Active/adverse effects; HIV Infections/drug therapy; Liver/drug effects; Protease Inhibitors/adverse effects; Adult; Cohort Studies; Female; HIV Infections/complications; Humans; Italy; Liver/enzymology; Liver/pathology; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / HIV Infections / Antiretroviral Therapy, Highly Active / Liver Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2001 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links